• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝状病毒感染 STAT-1 基因敲除小鼠。

Filovirus infection of STAT-1 knockout mice.

机构信息

Department of Veterinary Pathology, Armed Forces Institutes of Pathology, Washington, District of Columbia, USA.

出版信息

J Infect Dis. 2011 Nov;204 Suppl 3:S986-90. doi: 10.1093/infdis/jir335.

DOI:10.1093/infdis/jir335
PMID:21987780
Abstract

We evaluated the susceptibility to Ebola and Marburg virus infection of mice that cannot respond to interferon (IFN)-α/β and IFN-γ because of deletion of the STAT-1 gene. A mouse-adapted Zaire ebolavirus (ZEBOV) caused rapidly lethal disease; wild-type ZEBOV and Sudan Ebolavirus and 4 different Marburg virus strains produced severe, but more slowly progressive illness; and Reston Ebolavirus caused mild disease that was late in onset. The virulence of each agent was mirrored by the pace and severity of pathologic changes in the liver and lymphoid tissues. A virus-like particle vaccine elicited strong antibody responses but did not protect against mouse-adapted ZEBOV challenge.

摘要

我们评估了不能对干扰素(IFN)-α/β和 IFN-γ产生反应的 STAT-1 基因缺失小鼠对埃博拉和马尔堡病毒感染的易感性。一种适应于小鼠的扎伊尔埃博拉病毒(ZEBOV)引起了快速致命的疾病;野生型 ZEBOV 和苏丹埃博拉病毒以及 4 种不同的马尔堡病毒株引起了严重但进展更缓慢的疾病;而莱斯顿埃博拉病毒则引起了发病较晚的轻度疾病。每种病原体的毒力都反映在肝脏和淋巴组织病理变化的速度和严重程度上。一种类似病毒的颗粒疫苗引起了强烈的抗体反应,但不能预防适应于小鼠的 ZEBOV 挑战。

相似文献

1
Filovirus infection of STAT-1 knockout mice.丝状病毒感染 STAT-1 基因敲除小鼠。
J Infect Dis. 2011 Nov;204 Suppl 3:S986-90. doi: 10.1093/infdis/jir335.
2
Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.一种基于cAdVax的二价埃博拉病毒疫苗的研发,该疫苗可诱导针对苏丹型和扎伊尔型埃博拉病毒的免疫反应。
J Virol. 2006 Mar;80(6):2738-46. doi: 10.1128/JVI.80.6.2738-2746.2006.
3
A single shot against Ebola and Marburg virus.针对埃博拉病毒和马尔堡病毒的单次注射。
Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720.
4
[Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].[埃博拉和马尔堡出血热病毒:丝状病毒最新情况]
Med Trop (Mars). 2011 Apr;71(2):111-21.
5
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.单次注射疫苗可保护非人灵长类动物免受马尔堡病毒和三种埃博拉病毒的感染。
J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22.
6
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.单价三价囊泡疫苗可保护猕猴免受致命埃博拉病毒和马尔堡病毒的挑战。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01190-17. Print 2018 Feb 1.
7
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.重组蛋白丝状病毒疫苗可保护食蟹猴免受埃博拉、苏丹和马尔堡病毒的感染。
Front Immunol. 2021 Aug 18;12:703986. doi: 10.3389/fimmu.2021.703986. eCollection 2021.
8
Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.Stat1基因缺陷型小鼠并非用于基于重组水疱性口炎病毒的丝状病毒疫苗效力测试的合适模型。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S404-9. doi: 10.1093/infdis/jiv188. Epub 2015 May 28.
9
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.埃博拉病毒和马尔堡病毒的组织和细胞嗜性、病理学和发病机制。
J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.
10
A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.多聚体丝状病毒 DNA 疫苗经肌肉内电穿孔给药可完全保护小鼠免受埃博拉和马尔堡病毒的挑战。
Hum Vaccin Immunother. 2012 Nov 1;8(11):1703-6. doi: 10.4161/hv.21873. Epub 2012 Aug 24.

引用本文的文献

1
A surrogate BSL2-compliant infection model recapitulating key aspects of human Marburg virus disease.一种符合生物安全水平2级要求的替代感染模型,概括了人类马尔堡病毒病的关键特征。
Emerg Microbes Infect. 2025 Dec;14(1):2449083. doi: 10.1080/22221751.2024.2449083. Epub 2025 Jan 12.
2
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
3
A lethal mice model of recombinant vesicular stomatitis viruses for EBOV-targeting prophylactic vaccines evaluation.
用于埃博拉病毒靶向预防性疫苗评估的重组水疱性口炎病毒致死性小鼠模型。
Virol Sin. 2024 Jun;39(3):516-519. doi: 10.1016/j.virs.2024.03.008. Epub 2024 Mar 24.
4
Animal Model Alternatives in Filovirus and Bornavirus Research.动物模型在丝状病毒和博尔纳病毒研究中的应用。
Viruses. 2023 Jan 4;15(1):158. doi: 10.3390/v15010158.
5
Macrophage infection, activation, and histopathological findings in ebolavirus infection.埃博拉病毒感染中的巨噬细胞感染、激活和组织病理学发现。
Front Cell Infect Microbiol. 2022 Oct 12;12:1023557. doi: 10.3389/fcimb.2022.1023557. eCollection 2022.
6
Bridging Animal and Human Data in Pursuit of Vaccine Licensure.为追求疫苗许可而搭建动物与人类数据的桥梁。
Vaccines (Basel). 2022 Aug 25;10(9):1384. doi: 10.3390/vaccines10091384.
7
STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV).STAT-1 敲除小鼠作为野生型苏丹病毒(SUDV)的模型。
Viruses. 2021 Jul 17;13(7):1388. doi: 10.3390/v13071388.
8
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.埃博拉病毒的物种和变体特异性的致病性和毒力。
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
9
Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.研究负链RNA病毒与其宿主之间的相互作用以促进疫苗开发与生产。
Vaccines (Basel). 2021 Jan 17;9(1):59. doi: 10.3390/vaccines9010059.
10
Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy .用于评估抗丝状病毒单克隆抗体疗效的病毒接种和治疗方案
Biosaf Health. 2019 Jun;1(1):6-13. doi: 10.1016/j.bsheal.2019.02.004. Epub 2019 Mar 1.